Cobenfy Falls Short as Add-On Therapy for Schizophrenia ...Middle East

Compared with placebo, xanomeline/trospium as an add-on to atypical antipsychotics has not reached the threshold for a statistically significant difference, top-line data show. Medscape Medical News

Hence then, the article about cobenfy falls short as add on therapy for schizophrenia was published today ( Friday 25/04/2025 - 02:43 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cobenfy Falls Short as Add-On Therapy for Schizophrenia )

Also on site :

• Germany’s Merz changes stance on Russia
• Tokyo's Yamanote Line suspended due to power outage
• 2000s Heavy Metal Band Shares Exciting Music Festival News